期刊文献+

苗勒管抑制物质在尿道下裂发病中的作用 被引量:1

The role of mullerian inhibiting substance in the development of hypospadias
原文传递
导出
摘要 目的探讨苗勒管抑制物质(MIS)在尿道下裂发病中的作用。方法分别检测54例单纯型尿道下裂及36例无泌尿生殖系统疾病儿童血清苗勒管抑制物质、睾酮及雄烯二酮的水平。结果尿道下裂组和对照组儿童的血清MIS平均值分别为(122.0±21.7)ng/ml和(80.5±11.4)ng/ml,P〈0.01。对照组儿童血清睾酮为(1.55±0.42)pg/ml,尿道下裂组儿童为(0.64±0.31)pg/ml,P〈0.05。对照组儿童血清雄烯二酮的水平明显高于尿道下裂组儿童,分别为(1.41±0.28)ng/ml和(0.66±0.19)ng/ml,P〈0.01。尿道下裂儿童较高的MIS水平和较低的睾酮水平呈较弱的负相关。结论尿道下裂儿童血清苗勒管抑制物质的水平与睾酮水平呈负相关,苗勒管抑制物质可能通过抑制睾酮的合成进而在尿道下裂的发病中发挥作用。 Objective To explore the role of mullerian inhibiting substance in the development of male hypospadias. Methods Fifty-four isolated hypospadias patients and 36 patients which suffered from other diseases were chosen as our research objects. Of the hypospadias patients, there were 11 patients were less than 12 months,24 patients from 13 to 24 months,and 19 patients from 25 to 36 months. Serum mullerian inhibiting substance, testosterone, and androstenedione were assayed, respectively. And the differences of the testosterone and mullerian inhibiting substance between these two groups were compared. Results The concentration of mullerian inhibiting substance in hypospadias group (122.0 ±21.7 ng/ml) was significantly higher than that in control group (80.5±11.4 ng/ ml). While the concentrations of testosterone and androstenedione in hypospadias group were significandy lower than those in control group. Furthermore, these two groups were divided into 3 subgroups according to their age. The concentrations of testosterone and androstenedione in hypospadias group whose age was less than 12 months and 13 to 24 months were significantly lower than those in control group. And the higher concentration of mullerian inhibiting substance was negatively related to the lower concentration of testosterone in hypospadias patients, and the relative coefficient was negative 0.31 and 0. 42, respectively. Conclusions Mullerian inhibiting substance may inhibit the synthesization of testosterone. Mullerian inhibiting substance plays a part in the development of hypospadias.
出处 《中华小儿外科杂志》 CSCD 北大核心 2008年第4期224-226,共3页 Chinese Journal of Pediatric Surgery
  • 相关文献

参考文献10

  • 1Laurich VM, Trbovich AM, O'neill FH, et al. Mullerian inhib iting substance blocks the protein kinase a-induced expression of cytochrome P450 17 hydroxylase/C17 20 lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation. Endocrinology. 2002, 143: 3351-3360.
  • 2Racine C. Rey R, ForestMG. et al. Receptors for antimullerian hormone on Leydig cells are responsible for its effect on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA. 1998, 95 : 594-599.
  • 3Sriraman V, Niu E, Matias JR, et al. Mullerian inhibiting substance inhibits testosterone synthesis in adult rats. J Androl, 2001, 22:750-758.
  • 4Utsch B, Albers N, Ludwig M. Genetic and molecular aspects of hypospadias. J Pediatr Surg. 2004 . 14:297-302.
  • 5Austin PF, Siow Y, Fallet ME, et al. The relationship between mullerian inhibiting substance and androgens in boys with hypos padias. J Urol, 2002, 168:1784-1788.
  • 6Teixeira J, Maheswaran S, Donahoe PK. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev, 2001, 22:657- 674.
  • 7Josso N, di Clemente N, Goue dard L. Anti Mullerian hormone and its receptors. Mol Cell Endocrinol, 2001, 179:25-32.
  • 8Lukas Croisier CL. Lasala C. Nicaud J. et al. Follicle-stimula ting hormone increases testicular anti-mu llerian hormone (AMH) production through Sertoli cell proliferation and a nonclassical cyclic adenosine 5-monophosphate-mediated activation of the AMH gene. Molecular Endocrinology, 2003, 17:5511-561.
  • 9Teixeira J, Fynn-Thompson E, Payne A, et al. Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level. Endocrinology, 1999, 140: 4732-4738.
  • 10Lee MM, Seah CC, Masiakos PT, et al. Mullerian inhibiting substance type 11 receptor expression and function in purified rat Leydig cells. Endocrinology, 1999, 140 : 2819-2827.

同被引文献38

  • 1姜海洋,孔北华.抗苗勒氏管激素基因表达调控[J].中国优生与遗传杂志,2005,13(3):9-10. 被引量:1
  • 2刘国昌,温英泉,袁继炎,周学锋,张文,郭辉.苗勒管抑制物质在儿童外生殖器畸形诊断中的价值[J].中华小儿外科杂志,2006,27(8):410-413. 被引量:8
  • 3李强辉,杨体泉.小儿高位隐睾的治疗进展[J].临床小儿外科杂志,2007,6(5):46-47. 被引量:3
  • 4Nilson O. Hernia uteri inguinalis beim manne[J]. Acta Chir Scand, 1939,83 : 231.
  • 5Rasool N, Safdar CA, Ahrnad A, et al. Transverse testicular ectopia with persistent mullerian duct syndrome: a case report [J]. Pakistan Armed Forces Med J,2012,6:2.
  • 6Akdemir AO. Transverse testicular eetopia in an adult male; a rare form of persistent rnullerian duct syndrome: a case report [J] . J Clin Anal Med,2013,4(2):143-145.
  • 7Shalaby MM, Kurkar A, Zarzour MA, et al. The management of the persistent Mullerian duct syndrome[J]. Arab J Urol, 2014,12(3) :239-244. DOI: 10. 1016/j. aju. 2014. 04. 001.
  • 8Renu D, Rao BG, Ranganath K,et al. Persistent m llerian duct syndrome[J]. Indian J Radiol Imaging, 2010, 20 ( 1 ) : 72-74. DOI: 10. 4103/0971-3026. 59761.
  • 9Knebelmann B, Boussin L, Guerrier D, et al. Anti-M llerian hormone Bruxelles: a nonsense mutation associated with the persistent M llerian duct syndrome[J]. Proc Natl Acad Sci USA, 1991,88(9) :3767 3771.
  • 10Loeff DS, Imbeand S, Reyes HM, et al. Surgical and genetic aspects of persistent miillerian duct syndrome [J]. J Pediatr Surg, 1994,29(1) :61-65.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部